Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertoni

Showing results (61-70 of 325) with videos related to

Pageof 33
Sort By:
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidencesMarilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Gigabyte (Hong Kong, China)|March 23, 2023
HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocolsLodovico Terzi di Bergamo, Francesca Guidetti, Davide Rossi, et al.
British Journal of Haematology|December 28, 2016
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulationValentina Restelli, Micaela Vagni, Alberto J Arribas, et al.
Seminars in Cancer Biology|December 17, 2013
Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-typeCatherine Thieblemont, Francesco Bertoni, Christiane Copie-Bergman, et al.
Frontiers in Oncology|August 29, 2018
T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling PathwaysFrancesco Paduano, Eugenio Gaudio, Afua A Mensah, et al.
Targeted Oncology|February 15, 2018
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell LinesValentina Restelli, Monica Lupi, Micaela Vagni, et al.
The Journal of Experimental Medicine|May 24, 2006
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expressionAnnalisa Macagno, Monica Molteni, Andrea Rinaldi, et al.
British Journal of Haematology|October 7, 2025
Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphomaNicolas Munz, Alberto J Arribas, Roberta Bordone Pittau, et al.
Frontiers in Veterinary Science|April 5, 2021
Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like LymphomaLuca Aresu, Chiara Agnoli, Arturo Nicoletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
<i>Dnmt3a</i> restrains mast cell inflammatory responsesCristina Leoni, Sara Montagner, Andrea Rinaldi, et al.
Pageof 33

Showing results (61-70 of 325) with videos related to

Sort By:
Pageof 33
Exploration of Targeted Anti-Tumor Therapy|January 19, 2023
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidencesMarilia Barreca, Noémie Lang, Chiara Tarantelli, et al.
Gigabyte (Hong Kong, China)|March 23, 2023
HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocolsLodovico Terzi di Bergamo, Francesca Guidetti, Davide Rossi, et al.
British Journal of Haematology|December 28, 2016
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulationValentina Restelli, Micaela Vagni, Alberto J Arribas, et al.
Seminars in Cancer Biology|December 17, 2013
Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-typeCatherine Thieblemont, Francesco Bertoni, Christiane Copie-Bergman, et al.
Frontiers in Oncology|August 29, 2018
T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling PathwaysFrancesco Paduano, Eugenio Gaudio, Afua A Mensah, et al.
Targeted Oncology|February 15, 2018
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell LinesValentina Restelli, Monica Lupi, Micaela Vagni, et al.
The Journal of Experimental Medicine|May 24, 2006
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expressionAnnalisa Macagno, Monica Molteni, Andrea Rinaldi, et al.
British Journal of Haematology|October 7, 2025
Polatuzumab vedotin and CD79B: A study of efficacy in R-CHOP-resistant diffuse large B-cell lymphomaNicolas Munz, Alberto J Arribas, Roberta Bordone Pittau, et al.
Frontiers in Veterinary Science|April 5, 2021
Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like LymphomaLuca Aresu, Chiara Agnoli, Arturo Nicoletti, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
<i>Dnmt3a</i> restrains mast cell inflammatory responsesCristina Leoni, Sara Montagner, Andrea Rinaldi, et al.
Pageof 33